---
title: CCRF-CEM CDX Model - TD2 Precision Oncology
description: CCRF-CEM is a prominent cell line used to study acute T cell lymphoblastic leukemia, aiding in the understanding of its biology and in the assessment of therapeutic responses.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/CCRF-CEM.jpg
---

×

 

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

# CCRF-CEM CDX Model

**Synonyms:** CEM

The CCRF-CEM cell line originates from human acute T cell lymphoblastic leukemia (T-ALL), a subtype of acute lymphoblastic leukemia that arises from T cell precursors. CCRF-CEM provides a valuable in vitro and in vivo model for understanding the biology, pathogenesis, and therapeutic responses of T-ALL. Exhibiting key molecular characteristics and genetic features of T-ALL, the CCRF-CEM cell line serves as a representative model for preclinical investigations related to this aggressive leukemia. Its behavior closely mimics the rapid proliferative nature of T-ALL, along with its interactions with the bone marrow microenvironment and potential for systemic dissemination. Researchers frequently utilize CCRF-CEM to gain deeper insights into T-ALL pathogenesis, the leukemia-stroma interactions, and to test and develop new therapeutic regimens, particularly those related to targeted and chemotherapeutic interventions.

## Model Details

**Cancer Location:** Intravenous   
**Cancer Type:** Acute T Cell Lymphoblastic Leukemia  
**Model Name:** CCRF-CEM  
**Mouse Strain:** NSG, CB.17 SCID

## CCRF-CEM Growth Curves

![CCRF-CEM CDX Model](https://td2inc.com/hubfs/Assets/GraphsFigures/CCRF-CEM.jpg)

Growth of subcutaneous CCRF-CEM in NSG mice (n=5)

### Request Additional CDX Model Data

## CONTACT US

## Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.

[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)

[![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en)

Office  
13208 E. Shea Blvd,   
Suite 100   
Scottsdale, AZ 85259

Phone  
(602) 358-8300

Connect with us

- <https://www.linkedin.com/company/translational-drug-development/>
- <https://twitter.com/TD2_Oncology>

![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png)

© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)